About this episode
CV outcomes in patients with type 2 diabetes, canagliflozin, cardiorespiratory fitness, the value of randomized trials, and the most important paper of 2018 are reviewed in this week's podcast.
Get every episode summarized
Each time This Week in Cardiology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Cardiology
Sep 11 2026 This Week in Cardiology
This Week in Cardiology
Sep 11, 202629:17completed
Sep 04 2026 This Week in Cardiology
This Week in Cardiology
Sep 4, 202641:27completed
Aug 28 2026 This Week in Cardiology
This Week in Cardiology
Aug 28, 202626:24pending
August 21 2026 This Week in Cardiology
This Week in Cardiology
Aug 21, 202633:02pending